Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
EBS compared with PBYI: revenue, margins and what each company keeps, and the suppliers and customers both name
EBS
Emergent BioSolutions Inc.
Change
Mkt cap
Revenue
Revenue
PBYI
Puma Biotechnology, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
EBS
Emergent BioSolutions Inc.
vs
PBYI
Puma Biotechnology, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
EBS, solid
PBYI, dashed
Supply-chain overlap
Revenue flow
EBS: latest quarter is a loss; flow not drawable.
Method
›
EBS
Emergent BioSolutions Inc.
Change
6.79
▼
−5.92%
· post 6.79
Mkt cap
$349.2M
Revenue
$234M
Q2 FY26
Revenue
$743M
FY25
PBYI
Puma Biotechnology, Inc.
Change
10.42
▼
−1.09%
· post 10.43
Closed
Oct 30 '26
Mkt cap
$538.9M
Revenue
$57M
Q2 FY26
Revenue
$228M
FY25
vs
Compare
Closed
Oct 30 '26
EBS
Emergent BioSolutions Inc.
vs
PBYI
Puma Biotechnology, Inc.
6.79
▼
−5.92%
post 6.79
Price
10.42
▼
−1.09%
post 10.43
$349.2M
Mkt cap
$538.9M
Q2 FY26
$234M
Revenue
$57M
Q2 FY26
FY25
$743M
Revenue
$228M
FY25
Change
Change
EBS
6.79
▼
−5.92%
vs
PBYI
10.42
▼
−1.09%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only EBS
14
MGNX
Macrogenics
supplier
SABS
SAB Biotherapeutics
customer
—
Hikma Pharmaceuticals
unlisted
supplier
—
Barda
unlisted
customer
10 more · EBS chain
›
Shared
0
No shared counterparties.
Only PBYI
18
PFE
Pfizer
supplier
CVS
CVS
customer
MCK
McKesson
customer
CAH
Cardinal Health
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
14 more · PBYI chain
›